Supplement: TX SB294 | 2023-2024 | 88th Legislature | Fiscal Note (Introduced)
For additional supplements on Texas SB294 please see the Bill Drafting List
Bill Title: Relating to the use of epinephrine auto-injectors and medication designated for treatment of respiratory distress on public and private school campuses.
Status: 2023-05-24 - Effective immediately [SB294 Detail]
Download: Texas-2023-SB294-Fiscal_Note_Introduced_.html
Bill Title: Relating to the use of epinephrine auto-injectors and medication designated for treatment of respiratory distress on public and private school campuses.
Status: 2023-05-24 - Effective immediately [SB294 Detail]
Download: Texas-2023-SB294-Fiscal_Note_Introduced_.html
TO: |
Honorable Brandon Creighton, Chair, Senate Committee on Education |
FROM: |
Jerry McGinty, Director, Legislative Budget Board
|
IN RE: |
SB294 by Johnson (Relating to the use of medication designated for treatment of respiratory distress on public and private school campuses.), As Introduced |
No significant fiscal implication to the State is anticipated.
It is assumed that any costs associated with the bill could be absorbed using existing resources.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies: b > td > | 537 State Health Services, Department of, 701 Texas Education Agency, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration, 758 Texas State University System, 768 Texas Tech University System Administration, 769 University of North Texas System Administration, 783 University of Houston System Administration |
LBB Staff: b > td > | JMc, KSk, ASA, ENA |